The First Drug To Slow Alzheimer’s Won FDA Approval, But Critics Say We Don’t Know If It Actually Works. In one sense, aducanumab is a historic drug. But many scientists say that its approval is a triumph of business interests over public health. View Entire Post › June 07, 2021 Labels: News Share to: Twitter Facebook URL Print Email
Post a Comment